Search

This study analysed the cost-effectiveness of four different treatment modalities (medical therapy, PTA with and without stent, and surgery) for the therapy of renal-artery stenoses in hypertensive patients in Germany. A computerised, predictive decision-analytic model, based on economic input data and the cost of medical care in Germany, and the results of published data from prospective clinical trials, was developed. The economic analysis was performed from the perspective of a third-party payer. The base-case analysis showed that the primary end-point (major vascular bleeding, stroke, dialysis, or repeat arterial revascularisation) was reached at 36 months by 82.4% of the patients in the medical treatment group, 81.4% in the angioplasty group, 52.9% in the surgical group and 27.7% in the stent group. The average reimbursed treatment cost per patient after 3 years was € 9121 (medication), € 17 164 (surgery), € 14 670 (PTA), and € 8437 (stent). This resulted in a cost-effectiveness ratio of € 51 752 (medical treatment), € 36 454 (surgery), € 78 766 (PTA), and € 11 663 (stent) per event-free patient at 3 years. The accelerated cost-development after balloon dilatation was caused by higher rates of restenosis compared with primary stent implantation. The analysis of published prospective clinical data and current economic variables for renovascular interventions leads to the conclusion that a strategy using primary stent implantation is more cost-effective than stand-alone balloon dilatation. Both medical therapy and surgery offer a better cost-effectiveness ratio than PTA treatment alone. [ABSTRACT FROM AUTHOR]

Aim: The effects of endurance training and of exhaustive treadmill running on low density lipoprotein (LDL) oxidation in women are not clearly established., Methods: Twenty training and 10 control persons, all not endurance trained, aged 26+/-4 and 23+/-3 years, were recruited for 8 weeks of running training 3x/week 30 min. The susceptibility of LDL to in vitro oxidation, conjugated dienes, malondialdehyde (MDA), nitric oxide (NO) and cholesterol, lipoproteins, triglycerides, apolipoprotein (apo) A-I, apo B and lipoprotein (a) were determined before and after training, at rest and after exhaustive spiroergometric exercise. The training was tailored individually at the speed of the 4 mmol/L lactate threshold., Results: At rest and after treadmill running, training induced an increase in lag-time (P<0.05), a decrease in MDA (P<0.05), and lower values for cholesterol (P<0.001), LDL (P<0.01), triglycerides (P<0.05) and apo B (P<0.001), but no increase for high density lipoprotein (HDL) or apo A-I. Before training, treadmill running induced lower conjugated dienes and malondialdehyde, after training an increase for LDL and decrease for cholesterol and triglycerides, no increase for HDL or apo A-I. In the control group, all parameters remained unchanged, only NO lowered (P<0.01)., Conclusion: Endurance training in women shows favorable effects on LDL oxidation, cholesterol, LDL-cholesterol, triglycerides and apo B.

The aim of this study was to analyze the feasibility of (188)Re-labeled stents to reduce neointimal formation in a rabbit atherosclerosis model and to test the long-term effects at 7 and 26 weeks. Fifty-nine male New Zealand White rabbits were fed a 0.5% cholesterol diet for 4 weeks before balloon angioplasty and insertion of Palmaz stents in the infrarenal aorta. The animals were sacrificed 7 and 26 weeks after stent implantation. Control stents were compared with (188)Re stents: (dose 1) 11.3 +/- 1.8 MBq; (dose 2) 37.3 +/- 4.2 MBq, and (dose 3) 80.1 +/- 7.8 MBq. Each activity group consisted of a short-term (7 weeks) and a long-term group (26 weeks), resulting in a total of eight study groups. No thrombotic occlusion was observed. The neointimal formation in the control group was 2.11 [95% confidence interval (CI): 0.68--6.52] mm(2) at 7 weeks and 2.10 (0.62--7.11) at 26 weeks. In the treatment groups, neointima reduction was detectable at 7 weeks [dose 1: 0.33 (0.09--1.22) mm(2); dose 2: 0.17 (0.05--0.57) mm(2); dose 3: 0.03 (0.01--0.13) mm(2)]. After 26 weeks, a catch-up of neointimal formation in the radioactive groups was most obvious in the low-dose group [dose 1: 0.80 (0.28--2.29) mm(2); dose 2: 0.18([0.06--0.52) mm(2); dose 3: 0.50 (0.17--1.42) mm(2)]. Compared to the long-term control group, neointimal reduction was still >60%. No induction of neointimal formation was observed at the edges of the stents. Radiation resulted in delayed re-endothelialization. (188)Re stents were capable to reduce intimal hyperplasia and did not cause thrombosis. The edge effect, which was the major limitation of (32)P stents, was not observed in (188)Re stents.

Objectives: The aim of the study was to test whether a mixed-mock-up-simulator (MMU-simulator) is suitable for on-the-job training by measuring stress reactions induced by handling a crane in a virtual environment in subjects not experienced in crane operation., Materials and Methods: A MMU-simulator in a virtual environment was developed. Twenty three individuals were randomly divided into Group 1 (n = 13) and Group 2 (n = 10). They had the task of transporting a weight over barriers with a virtual crane twice in two 15-min intervals with a 15-min break in between. Acoustical and optical disturbances were generated as an additional strain for Group 1 in the second interval and for Group 2 in the first interval. Heart rate (HR) and blood pressure (BP) were measured consecutively in both groups, blood sampling was performed in Group 1. Plasma concentrations of stress hormones and lipids were analyzed. Data were calculated as the percentage of baseline values., Results: Compared to rest courses, strain led to a significant increase in HR and BP except diastolic BP in Group 2. Apart from an increased systolic BP under additional stress in Group 2, no significant differences were found between the two strain courses. Concentrations of epinephrine showed the highest increase under strain with a mean of 67%. The mean increase in norepinephrine and cortisol was 23% and 7%, respectively, whereas a 4% increase was observed for total cholesterol and high density lipoprotein cholesterol. These differences between "Rest" and "Strain" were significant. After adjusting for total plasma protein concentration, stress hormones, but not lipids, were still significantly higher during strain., Conclusions: The elevation in lipids during acute stress could be interpreted as an effect of hemoconcentration due to vasoconstriction by catecholamines. The significant increase in cardiovascular parameters and stress hormones during the tasks demonstrate that working in a virtual environment generates mental strain and that the developed MMU-simulator appears to be a promising device for on-the-job training. However, further research is necessary to validate the usefulness of virtual training by means of a comparative study of virtual and real-world training.

Rationale and Objectives: The purpose of the study was to test the capability of the endothelin A receptor antagonist LU 135252 to reduce neointimal formation in rabbits after balloon denudation with and without the presence of hypercholesterolemia., Methods: Twenty-eight male New Zealand White rabbits underwent balloon denudation of the infrarenal aorta. The animals were randomly assigned to 1 of the 4 groups. After balloon denudation, group 1 (n = 6) and 2 (n = 7) received a standard diet, and group 3 (n = 8) and 4 (n = 7) were fed a 0.5% cholesterol diet. All interventional procedures were performed while the rabbits were under general anesthesia. One week prior to intervention treatment with LU 135252 was started in group 2 and 4. After 6 weeks the animals were killed for morphometric and histological analysis., Results: Rabbits in all treatment groups developed neointimal hyperplasia. By additional systemic treatment with LU 135252, the mean neointima to media ratio was significantly reduced only in the hypercholesterolemic animals of group 4 (neointimal to media ratio area of group 3 vs group 4: 2.07 +/- 0.62 vs 1.41 +/- 0.45, P < 0.05). ET receptor blockade in group 2 and 4 did not have an effect on plasma levels of cholesterol, very low-density lipoprotein-, high-density lipoprotein-, and low-density lipoprotein-cholesterol., Conclusion: LU 135252 was efficient in reducing lipid induced atherosclerotic changes but was ineffective in inhibiting restenosis induced by balloon denudation.

Background: Intraluminal beta-irradiation has been shown to decrease neointimal proliferation after angioplasty in experimental models. The purpose of this study was to test the technical feasibility and biological effects of (186)Re-labeled stents., Methods and Results: Thirty-four New Zealand White rabbits were fed a 0.5% cholesterol diet before balloon angioplasty and insertion of Palmaz stents in the infrarenal aorta. The animals were killed 7 weeks after stent implantation. Two of 34 animals died prematurely (aortic leak, pneumonia). Control stents (n=7) were compared with (186)Re stents (2.6 MBq [n=6], 8.1 MBq [n=5], 16.0 MBq [n=6], and 25.3 MBq [n=8]). Stent application was successful in all cases. No thrombus occlusion was observed. After 7 weeks, neointima formation was 2.2+/-0.2 mm(2) in the control group. In the treatment groups, a dose-dependent neointima reduction was detectable (0.5+/-0.5 mm(2) [2.6 MBq], 0.4+/-0.4 mm(2) [8.1 MBq], and 0 mm(2) [16.0 MBq, 25.3 MBq]). No induction of neointimal formation was observed at the edges of the stents. Radiation resulted in delayed reendothelialization., Conclusions: (186)Re stents were capable of reducing neointima formation in a dose-dependent fashion. (186)Re stents did not cause late thrombosis or neointimal induction at the stent margins in the observation period of 7 weeks.

Background: Oxidative stress is recognized as an essential mechanism of atherogenesis and plaque progression. However, the origin of increased free radical production has not yet been well described. Furthermore, therapy with antioxidants has not shown convincing results., Objective: To consider questions concerning the impact of oxidative stress, and the effects and usefulness of antioxidants., Animals and Methods: Atherosclerotic plaques were induced in rabbits by feeding them a cholesterol-rich diet (2%) for six weeks. Thereafter a normal diet was given up to 68 weeks. Body weight, food intake, plasma lipid concentration and antioxidative capacity were determined at various time intervals. Aortic plaque size, morphology and radical production were determined in groups of animals killed after six, 14, 21, 29, 40 and 74 weeks, and compared with values in untreated controls. Chemiluminescent methods were used to determine antioxidative capacity of plasma, generation of free radicals and redox reactivity of various antioxidants., Results: Antioxidative capacity, occurrence of modified low density lipoprotein and generation of free radicals indicated oxidative stress during plaque progression; however, they showed different correlations to cellular components of the plaques. Furthermore it was shown that some antioxidants have both anti- and pro-oxidative properties., Conclusions: Oxidative stress during atherogenesis seems to correlate with different phases of plaque development and can be associated with different types of reactive species. Because plaque remodelling and stabilization may also be a phase of increased free radical generation, therapeutic antioxidants must exert specific and selective activity; in particular, whether their oxidized form acts pro-oxidatively must be determined.

Rationale and Objectives: Several radiopharmaceuticals were administered through a porous balloon catheter to compare the absolute amount deposited and the retention in the vessel wall. The reported efficiency of local drug delivery ranges from 0.001% to 0.1%, with poor retention after 24 hours., Methods: An endothelin derivative (n = 6), pertechnetate (n = 6), hexamethylpropylene amineoxime (HMPAO) (n = 5), ethyl cysteinate dimer (ECD) (n = 5), and tin colloid (n = 5) were labeled with 185 MBq/mL 99m-technetium. After balloon denudation of the infrarenal aorta in 27 New Zealand White rabbits, 100 microL of each agent was administered through a porous balloon at a pressure of 4 bar. Dynamic and static whole-body scintigrams were obtained for 24 hours. The infrarenal aorta was excised and the activity calculated in a gamma counter., Results: Apart from their retention in the region of local administration, the radiopharmaceuticals showed different distribution patterns. The highest regional tracer retention was observed with HMPAO. After administration of HMPAO, a significant difference between regional (vessel wall plus surrounding tissue: 14.5% of injected dose [ID]/24 hours) and local (vessel wall: 1.8% ID/24 hours) delivery was found. In contrast, ECD was eliminated quickly (local retention after 24 hours = 0% ID). The retention efficiencies were HMPAO > endothelin derivative > tin colloid > pertechnetate > ECD., Conclusions: The different physicochemical and pharmacokinetic properties of radiopharmaceuticals resulted in different delivery efficiencies after local application.

Purpose: To test the hypothesis that local administration of angiotensin converting enzyme (ACE) inhibitor via a microporous balloon catheter would be more effective than oral administration of ACE inhibitor in preventing neointima formation after balloon angioplasty., Materials and Methods: Neointima formation was induced by balloon denudation followed by 0.5% cholesterol diet in 29 New Zealand White rabbits. Directly after denudation, local administration of 1.8 mg of ramiprilat (n = 7) or saline (n = 7) with a microporous balloon catheter at a pressure of 3 atm was performed. Both groups additionally received ramipril orally (1 mg/d). Seven animals were treated exclusively with oral ramipril. The control group was fed a 0.5% cholesterol diet and given no medication (n = 8). Six weeks after intervention, the animals were killed and morphometric and immunohistologic analyses were performed., Results: Oral administration of ramipril resulted in a significant reduction of placque area (-66%, P < .05). Oral and local administration of the ACE inhibitor was followed by a nonsignificant reduction of the neointimal area (-17%). Local administration of saline combined with oral ramipril failed to prevent neointimal formation (reduction of 6%, NS)., Conclusion: Oral administration of ramipril resulted in a significant reduction of neointimal proliferation in New Zealand White rabbits. The possible benefit of an additional administration of local ramiprilat was diminished by an excessive neointimal hyperplasia, which was most likely caused by the inherent vessel trauma with use of the microporous balloon catheter.

ERT is associated with a reduced incidence of coronary risk and cardiac events in postmenopausal women, but increases the risk of endometrial hyperplasia and carcinoma. Combined estrogen and progestin therapy protects the endometrium; however, its effects on heart disease risk factors are not completely known. In our study, 56 ovariectomized New Zealand White rabbits in 7 groups received a 0.5% cholesterol diet for 12 weeks. Controls were not treated with hormones. All other animals received (per kilogram body weight per week) intramuscular injections of either 0.3 mg estrogen (estradiol valerate) alone, 8.3 mg progestin (hydroxyprogesterone caproate) alone, estrogen and progestin continuously in 3 different dosages (0.3 and 8.3 mg; 1 and 8.3 mg; or 1 and 2.8 mg; estrogen and progestin, respectively), or 1 mg estrogen with 25 mg progestin sequentially in 2-week cycles. Eight non-ovariectomized animals served as further controls for endometrial analysis. Morphometric analysis of plaque size in the aortic arch showed that estrogen monotherapy, and the 3 combined therapies with 1 mg estrogen, significantly reduced intimal thickening (P<0.05). The application of progestin alone had no effect on plaque size. The endometrium was enlarged by 3-fold after estrogen treatment, and was decreased by half after progestin treatment, compared with control uteri (P<0.05). In all groups with combined hormone regimens, endometrial size was not significantly different from control uteri. However, these uteri showed more inflammatory reactions, especially when higher doses of hormones were given. In this animal model, doses of progestin that are able to successfully reduce the proliferative effect of estrogen on endometrium do not diminish the desirable antiatherosclerotic properties of estrogen.

The rabbit has been a widely accepted animal model for atherosclerosis research since Anitschkow first used this animal in 1913 in identifying dietary-induced hypercholesterolemia as a major risk factor for atherogenesis. Experiments with cholesterol-fed rabbits have demonstrated the beneficial effects of estrogen treatment on the development of atheroma for more than 50 y. Clinical trials have found a reduction in cardiovascular events of up to 50% in postmenopausal women receiving estrogen replacement therapy. However, metabolic conditions in rabbits, as well as physiological estrogen serum levels, differ in some aspects from those in humans. In rabbits, experimentally-induced hormone levels are about 5- to 10-fold higher than those found in untreated animals. Normal physiological estrogen levels in rabbits are not cardioprotective under dietary-induced hypercholesterolemia. We investigated whether replacement induced "hyperestrogenemia" causes adverse effects on organs other than the cardiovascular system. Twenty-nine female rabbits were divided into 4 different groups, 2 without and 2 with estrogen treatment (1 mg estradiol valerate/kg body weight/w over 12 w). Organ weights, transaminases and uterine histology were examined. In rabbits treated with estrogen, we did not see relevant adverse effects on heart, kidney and liver weights, or on liver enzymes. But there was a significant increase in spleen weights, as well as notable changes in the endometrium with moderate inflammation. These findings indicate that the dosage of estrogen commonly used for atherosclerosis research does not cause serious disorders in the major organs of cholesterol-fed rabbits.

Purpose: For evaluation of therapy for possible reduction of restenosis after PTA a suitable animal model is needed. The influence of different interventions on arterial plaque composition was analysed in New Zealand White Rabbits., Material and Methods: The following interventions were performed in the infrarenal aorta of New Zealand White Rabbits (n = 42): a) Balloon denudation (BD) with and b) without 0.5% cholesterol diet (CD), c) application of a Wiktor stent, d) CF without BD, and e) control group, 6 weeks after intervention morphometry and histology were performed., Results: After BD the stenosis rate measured 26 +/- 18%, additional CD after prior BD increased the stenoses rate by 2.5 times up to 61.1%. After stent implantation there was only a thin neointimal layer (89 +/- 68 microns) around the stent wires., Conclusions: Neither implantation of stents nor single CD are suitable as restenosis models. BD with and without CD was followed by a distinct neointima formation with different cellular composition. The New Zealand White Rabbit constitutes an acceptable model for contemporary research in arteriosclerosis.

The aim of the present study was to investigate whether there are gender-specific differences in the effects of testosterone and estrogen on the process of atherogenesis. Thirty-two castrated male and 32 ovariectomized female rabbits were separated into 4 study groups of 8 males and 8 females each and received postoperatively a 0.5% cholesterol diet for 12 weeks. During this period either no hormones, estradiol (1 mg/kg body wt/week), testosterone (25 mg/kg body wt/week IMM), or estrogen combined with testosterone in above dosages were administered. Computerized morphometric analysis of the intimal thickening in the proximal aortic arch showed a significant inhibitory effect of estrogen in female and of testosterone in male animals (P < .05). In the group with combined treatment, the plaque size in both sexes was smaller than in the animals of the control group (P < .05). These differences were independent of changes in plasma lipid parameters. The incorporation of 5'-bromo-2'-deoxyuridine, associated with cell proliferation, into cells of the neointima was not significantly affected by the different hormone application regimens in males. In females, the incorporation rate was significantly lowered in the estrogen treated group compared with the control group (P < .05). Due to the observed differences in the sex specific atheroprotective effects of testosterone and estrogen, these data suggest that complex hormone interactions, which are independent of changes in plasma lipids, may play an important role in the process of atherogenesis.

Background: The role of triglycerides as a risk factor for coronary artery disease (CAD) is controversial. In prospective studies, which have reported discrepant results, triglycerides have generally been measured with subjects in the fasting state. Taking into account the fact that the average person spends up to 18 h per day in the post-prandial state, fasting triglyceride levels alone are inadequate to describe the actual effective concentrations, metabolism and atherogenicity of triglyceride-rich lipoproteins. Therefore, investigations of the dynamic post-prandial triglyceride metabolism of patients with CAD in comparison with healthy controls are necessary., Methods: We studied the post-prandial metabolism of lipids in 99 men: 50 male patients with CAD confirmed by angiography and 49 matched healthy men. After an overnight fast of 12 h, the subjects (aged 40-60 years) ate a standardized oral fat load (3.2 MJ; 49 g fat = 58% of the total energy content). Blood samples for lipid analyses were drawn immediately prior to and hourly during the 6 h period after ingestion of the meal., Results: As required by the study design, fasting triglyceride and total cholesterol levels did not differ between patients and controls; however, high-density lipoprotein (HDL), HDL2 and HDL3 cholesterol levels were significantly lower in the CAD patients. The highest post-prandial triglyceride serum concentrations were observed 3 h after ingestion of the oral fat load both in cases and in controls. Generally, CAD patients had slightly higher triglyceride values than did controls and, at the 5 h measurement point, this difference was significant., Conclusions: The results suggest that there are differences in triglyceride metabolism between patients with CAD and healthy controls after a challenge with a moderate amount of fat. These differences can best be observed in the degradation phase of post-prandial lipaemia.